GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $38.10 $43.42 Thursday, 18th Apr 2024 CLDX stock ended at $38.53. This is 2.78% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 3.89% from a day low at $38.31 to a day high of $39.80.
90 days $34.65 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
2021-07-07 $31.26 $31.75 $28.30 $28.95 1 026 578
2021-07-06 $34.20 $34.21 $31.17 $31.30 591 057
2021-07-02 $34.42 $34.81 $33.25 $33.85 532 906
2021-07-01 $33.50 $35.00 $33.50 $34.43 505 382
2021-06-30 $35.08 $35.23 $32.90 $33.44 1 016 666
2021-06-29 $34.90 $35.69 $34.40 $35.37 569 864
2021-06-28 $32.74 $35.16 $32.24 $34.99 552 794
2021-06-25 $32.24 $34.13 $31.81 $32.51 5 349 476
2021-06-24 $30.33 $33.23 $30.20 $31.99 806 572
2021-06-23 $28.89 $30.40 $28.89 $30.01 401 854
2021-06-22 $28.40 $28.92 $27.94 $28.75 594 145
2021-06-21 $28.13 $29.11 $27.80 $28.25 443 540
2021-06-18 $27.71 $28.39 $26.80 $27.78 1 192 378
2021-06-17 $27.90 $29.30 $26.75 $28.00 417 296
2021-06-16 $29.24 $29.59 $27.56 $27.79 348 994
2021-06-15 $30.82 $30.82 $28.96 $29.20 283 389
2021-06-14 $31.04 $31.16 $30.30 $30.64 444 263
2021-06-11 $30.18 $31.06 $30.07 $31.04 451 114
2021-06-10 $30.05 $30.74 $29.66 $30.56 315 735
2021-06-09 $29.66 $30.33 $29.40 $30.05 405 576
2021-06-08 $28.50 $29.83 $28.10 $29.65 645 033
2021-06-07 $27.67 $28.96 $27.60 $28.50 746 392
2021-06-04 $28.31 $28.70 $27.12 $27.91 203 918
2021-06-03 $28.05 $28.76 $27.71 $28.07 240 957
2021-06-02 $27.93 $28.16 $27.22 $28.01 488 357
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT